Literature DB >> 24856568

Bipolar and panic disorders may be associated with hereditary defects in the innate immune system.

Leslie Foldager1, Ole Köhler2, Rudi Steffensen3, Steffen Thiel4, Ann Suhl Kristensen5, Jens Christian Jensenius4, Ole Mors2.   

Abstract

BACKGROUND: Mannan-binding lectin (MBL) and mannan-binding lectin-associated serine protease-2 (MASP-2) represent important arms of the innate immune system, and different deficiencies may result in infections or autoimmune diseases. Both bipolar and panic disorders are associated with increased inflammatory response, infections and mutual comorbidity. However, associations with MBL, MASP-2 or the gene, MBL2, coding for MBL, have not been investigated thoroughly.
METHODS: One hundred patients with bipolar disorder, 100 with panic disorder and 349 controls were included. Serum concentrations of MBL and MASP-2 were measured and seven single nucleotide polymorphisms (SNPs) influencing these concentrations were genotyped. Disease association with genetic markers and serum levels were investigated.
RESULTS: In panic disorder, we observed a large proportion (30%) of MBL deficient (<100ng/ml) individuals and significantly lower levels of MBL and MASP-2 plus association with the MBL2 YA two-marker haplotype. Bipolar disorder was associated with the MBL2 LXPA haplotype and lower MASP-2 levels. LIMITATIONS: No information on course or severity of disorders was included, and only MBL and MASP-2 were measured, excluding other components from the complement pathway. Restrictions defined by ethnical committees preclude information of control׳s ethnic origin.
CONCLUSIONS: Significant differences in MBL and MASP-2 concentrations were observed between cohorts, especially an intriguing finding associating panic disorder with MBL deficiency. These differences could not be fully explained by allele or haplotype frequency variations. Since MBL deficiency is highly heterogeneous and associated with both infectious and autoimmune states, more research is needed to identify which complement pathway components could be associated with bipolar respectively panic disorder.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Innate immune system; Mannan-binding lectin (MBL); Mannan-binding lectin-associated serine protease-2 (MASP-2); Panic disorder

Mesh:

Substances:

Year:  2014        PMID: 24856568     DOI: 10.1016/j.jad.2014.04.017

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents.

Authors:  Ole Köhler-Forsberg; Liselotte Petersen; Christiane Gasse; Preben B Mortensen; Soren Dalsgaard; Robert H Yolken; Ole Mors; Michael E Benros
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

Review 2.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

Review 3.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 4.  Is it time for immunopsychiatry in psychotic disorders?

Authors:  Marion Leboyer; José Oliveira; Ryad Tamouza; Laurent Groc
Journal:  Psychopharmacology (Berl)       Date:  2016-03-18       Impact factor: 4.530

5.  Individuals hospitalized with acute mania have increased exposure to antimicrobial medications.

Authors:  Robert Yolken; Maria Adamos; Emily Katsafanas; Sunil Khushalani; Andrea Origoni; Christina Savage; Lucy Schweinfurth; Cassie Stallings; Kevin Sweeney; Faith Dickerson
Journal:  Bipolar Disord       Date:  2016-07-17       Impact factor: 6.744

6.  Lifestyle Behaviours Add to the Armoury of Treatment Options for Panic Disorder: An Evidence-Based Reasoning.

Authors:  Rod Lambert
Journal:  Int J Environ Res Public Health       Date:  2015-06-18       Impact factor: 3.390

Review 7.  Infectious and immunogenetic factors in bipolar disorder.

Authors:  J Oliveira; A J Oliveira-Maia; R Tamouza; A S Brown; M Leboyer
Journal:  Acta Psychiatr Scand       Date:  2017-08-20       Impact factor: 6.392

8.  Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study.

Authors:  José Oliveira; Rémi Kazma; Edith Le Floch; Meriem Bennabi; Nora Hamdani; Djaouida Bengoufa; Mehdi Dahoun; Céline Manier; Frank Bellivier; Rajagopal Krishnamoorthy; Jean-François Deleuze; Robert Yolken; Marion Leboyer; Ryad Tamouza
Journal:  Int J Bipolar Disord       Date:  2016-05-20

Review 9.  Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression.

Authors:  Giampaolo Perna; Giuseppe Iannone; Alessandra Alciati; Daniela Caldirola
Journal:  Neural Plast       Date:  2015-12-31       Impact factor: 3.599

Review 10.  Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases.

Authors:  Fabiana Novellino; Valeria Saccà; Annalidia Donato; Paolo Zaffino; Maria Francesca Spadea; Marco Vismara; Biagio Arcidiacono; Natalia Malara; Ivan Presta; Giuseppe Donato
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.